← Leaderboards
Hunter Ramsdell Gibbons
Luminary Therapeutics, Inc.
$1,962,052
Attributed
$2,161,019
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$2,161,019 · 2
By mechanism
R44$1,861,249 · 1
R43$299,770 · 1
Top collaborators
- Andrew Kyle Lewis1 shared
Most similar at Luminary Therapeutics, Inc.
Same institution · by research overlap
- Nicole J. Shirkey-Son$1,017,866
- Andrew Kyle Lewis$198,967
Others in their field
Other Rising Stars on “î³î´ T Cells”
- Weiwei Wang · Ut Southwestern Medical Center$1,640,000
- Yi Ren · Cornell University$1,365,066
- Lai Wen · University Of Nevada Reno$1,115,298
- Nicole Jacqueline Camlin · Purdue University$922,059
- Peng Zhang · Case Western Reserve University$836,524
- Theresa Wampler Muskardin · Hospital For Special Surgery$790,560
Research focus
î³î´ T CellsInnovationDna TransposonsFamilyImmunotherapeutic AgentImproved OutcomeComplexCost EffectiveCell KillingEngineeringCellsChimeric Antigen Receptor T CellsChimeric Antigen ReceptorImmunotherapyB-LymphocytesCoculture TechniquesBindingCostAllogenicB-Cell ActivationCd19 GeneCar T Cell TherapyAntigensInterleukin 4 Receptor
Grant awards (3)
Allogeneic BAFF Ligand Based CAR T Cells as a Novel Therapy for B Cell Malignancies$1,463,315
R44 · FY2025 · CA · contact PI
Allogeneic BAFF Ligand Based CAR T Cells as a Novel Therapy for B Cell Malignancies$397,934
R44 · FY2023 · CA
Allogeneic BAFF Ligand Based CAR T-Cells as a Novel Therapy for Systemic Lupus Erythematous$299,770
R43 · FY2023 · AI · contact PI